Comparison of the Clinical Efficacy and Safety of Subcutaneous Versus Oral Administration of Methotrexate in Patients with Active Rheumatoid Arthritis: Results of a Six-Month, Multicenter, Randomized, Double- Blind, Controlled, Phase IV Trial

被引:0
|
作者
Brezinschek, Hans-Peter [1 ]
机构
[1] Med Univ Graz, Univ Klin Innere Med, Klin Abt Rheumatol, Auenbruggerplatz 15, A-8036 Graz, Austria
来源
JOURNAL FUR MINERALSTOFFWECHSEL | 2008年 / 15卷 / 02期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:106 / 107
页数:2
相关论文
共 50 条
  • [21] Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis - A double-blind, randomized, placebo-controlled trial
    van Dongen, Henrike
    van Aken, Jill
    Lard, Leroy R.
    Visser, Karen
    Ronday, H. Karel
    Hulsmans, Harry M. J.
    Speyer, Irene
    Westedt, Marie-Louise
    Peeters, Andre J.
    Allaart, Cornelia F.
    Toes, Rene E. M.
    Breedveld, Ferdinand C.
    Huizinga, Tom W. J.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (05): : 1424 - 1432
  • [22] A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis
    Wojtulewski, JA
    Schattenkirchner, M
    Barcelo, P
    LeLoet, X
    Bevis, PJR
    Bluhmki, E
    Distel, M
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 : 22 - 28
  • [23] Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial
    Choi, In Ah
    Baek, Han-Joo
    Cho, Chul-Soo
    Lee, Yeon-Ah
    Chung, Won Tae
    Park, Young Eun
    Lee, Yun Jong
    Park, Yong-Beom
    Lee, Jisoo
    Lee, Shin-Seok
    Yoo, Wan-Hee
    Song, Jung-Soo
    Kang, Seong Wook
    Kim, Hyun Ah
    Song, Yeong Wook
    BMC MUSCULOSKELETAL DISORDERS, 2014, 15
  • [24] Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial
    In Ah Choi
    Han-Joo Baek
    Chul-Soo Cho
    Yeon-Ah Lee
    Won Tae Chung
    Young Eun Park
    Yun Jong Lee
    Yong-Beom Park
    Jisoo Lee
    Shin-Seok Lee
    Wan-Hee Yoo
    Jung-Soo Song
    Seong Wook Kang
    Hyun Ah Kim
    Yeong Wook Song
    BMC Musculoskeletal Disorders, 15
  • [25] Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis
    Brandt, J
    Khariouzov, A
    Listing, J
    Haibel, H
    Sörensen, H
    Grassnickel, L
    Rudwaleit, M
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2003, 48 (06): : 1667 - 1675
  • [26] Efficacy and Safety of Sarilumab Versus Adalimumab in a Phase 3, Randomized, Double-Blind, Monotherapy Study in Patients with Active Rheumatoid Arthritis with Intolerance or Inadequate Response to Methotrexate
    Burmester, Gerd
    Lin, Yong
    Patel, Rahul
    van Adelsberg, Janet
    Mangan, Erin
    van Hoogstraten, Hubert
    Bauer, Deborah
    Ignacio Vargas, Juan
    Lee, Eun Bong
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [27] EFFICACY AND SAFETY OF SARILUMAB VERSUS ADALIMUMAB IN A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MONOTHERAPY STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH INTOLERANCE OR INADEQUATE RESPONSE TO METHOTREXATE
    Burmester, G.
    Lin, Y.
    Mangan, E.
    Van Hoogstraten, H.
    Vargas, J.
    Lee, E.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 26 - 26
  • [28] THE EFFICACY AND SAFETY OF SIROLIMUS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A RANDOMIZED AND PARALLEL-CONTROLLED CLINICAL TRIAL
    Wang, Jia
    Zhang, Sheng-xiao
    Hu, Fang Yuan
    Zheng, Xiao-Juan
    Cheng, Ting
    Yu, Na-Na
    Yang, Wen-Xian
    Gao, Chong
    Wen, Hong-Yan
    Li Xiao-Feng
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 738 - 738
  • [29] Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial
    Kim, Hyun-Sook
    Choi, Won-Ho
    Kim, Bo Young
    Kim, Sung Soo
    Lee, Sang-Il
    Kim, Sang-Hyon
    Choi, Sung Jae
    Kim, Geun-Tae
    Hur, Jin-Wuk
    Lee, Myeung-Su
    Kim, Yun Sung
    Hong, Seung-Jae
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (06)
  • [30] Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease
    Baum, Larry
    Lam, Christopher Wai Kei
    Cheung, Stanley Kwok-Kuen
    Kwok, Timothy
    Lui, Victor
    Tsoh, Joshua
    Lam, Linda
    Leung, Vivian
    Hui, Elsie
    Ng, Chelsia
    Woo, Jean
    Chiu, Helen Fung Kum
    Goggins, William B.
    Zee, Benny Chung-Ying
    Cheng, King Fai
    Fong, Carmen Yuet Shim
    Wong, Adrian
    Mok, Hazel
    Chow, Moses Sing Sum
    Ho, Ping Chuen
    Ip, Siu Po
    Ho, Chung Shun
    Yu, Xiong Wen
    Lai, Caroline Yau Lin
    Chan, Ming-Houng
    Szeto, Samuel
    Chan, Iris Hiu Shuen
    Mok, Vincent
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (01) : 110 - 113